Strattera

Strattera (Atomoxetine) – Detailed Product Description

Product Overview

Strattera is a prescription medication containing atomoxetine hydrochloride as its active ingredient. It belongs to the selective norepinephrine reuptake inhibitor (NRI/SNRI classification in the prescribing information) drug class and is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in adults and children aged 6 years and older.

Unlike stimulant medications commonly used to treat ADHD, Strattera is a non-stimulant treatment option. It works by influencing norepinephrine activity in the brain, a neurotransmitter involved in attention, impulse control, and behavioral regulation.

Strattera is intended to be used as part of a comprehensive ADHD treatment plan that may include psychological, educational, and social support.

Active Ingredient

• Brand Name: Strattera
• Generic Name: Atomoxetine
• Active Ingredient: Atomoxetine hydrochloride
• Drug Class: Selective norepinephrine reuptake inhibitor
• Therapeutic Category: ADHD medication
• Dosage Form: Oral capsules
• Administration Route: Oral
• Prescription Status: Prescription medication

Uses and Indications

Strattera is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in adults and pediatric patients aged 6 years and older.

ADHD is a neurodevelopmental disorder that can affect attention, impulse control, and activity levels. Under medical supervision, atomoxetine may help manage ADHD symptoms as part of an individualized treatment program.

Potential treatment goals may include:

• Supporting sustained attention.
• Helping manage impulsivity.
• Improving the ability to remain focused on tasks.
• Supporting behavioral symptom management.
• Contributing to an overall ADHD treatment plan.

Individual responses vary, and Strattera is not guaranteed to improve every symptom in every patient.

Mechanism of Action

Atomoxetine works primarily by inhibiting the reuptake of norepinephrine, increasing its availability in certain areas of the brain. Norepinephrine is involved in neural processes associated with attention and behavioral regulation.

Strattera is not an amphetamine-based stimulant. Its pharmacological action differs from that of traditional stimulant ADHD medications.

The medication’s effects, tolerability, and clinical response should be assessed by a qualified healthcare professional.

Available Strengths

Strattera capsules are available in the following strengths according to the U.S. prescribing information:

Availability may vary by country, manufacturer, and market. Confirm the specific strength and formulation against the product packaging and applicable regulatory information.

Dosage and Administration

Strattera dosage is individualized according to factors such as age, body weight, clinical response, tolerability, liver function, and relevant medication interactions.

The U.S. prescribing information provides weight-based recommendations for children and adolescents weighing less than 70 kg, and fixed-dose recommendations for patients weighing 70 kg or more and adults.

The medication may be taken with or without food. Capsules should be swallowed whole and should not be opened.

Important: The dosage information on a product listing must not be treated as an individualized prescription. A healthcare professional should determine the appropriate dose and treatment schedule.

Potential Benefits

Strattera may be prescribed to help manage symptoms associated with ADHD. The intended clinical benefits may include improvements in attention and impulse-control symptoms.

Response to treatment varies between individuals. Strattera is not a general-purpose cognitive enhancer, and it should not be marketed as a guaranteed way to increase intelligence, productivity, or academic performance.

Common Side Effects

Possible adverse reactions reported in clinical studies include:

Pediatric patients:

• Nausea
• Vomiting
• Fatigue
• Decreased appetite
• Abdominal pain
• Somnolence (drowsiness)

Adults:

• Constipation
• Dry mouth
• Nausea
• Decreased appetite
• Dizziness
• Erectile dysfunction
• Urinary hesitancy

Not every patient experiences side effects. Consult a healthcare professional if symptoms are persistent, severe, or concerning.

Warnings and Precautions

Strattera has important safety considerations that should be reviewed before use.

Suicidal thoughts and behaviors: The medication carries a boxed warning regarding an increased risk of suicidal ideation in pediatric patients aged 6 years and older. Children and adolescents receiving treatment should be monitored for suicidal thoughts, clinical worsening, and unusual behavioral changes, particularly during the initial months of treatment and after dosage changes.

Liver injury: Severe liver injury has been reported. Patients who develop jaundice or laboratory evidence of liver injury require prompt medical evaluation, and the prescribing information recommends discontinuing Strattera and not restarting it in those circumstances.

Cardiovascular effects: Strattera may increase blood pressure and heart rate. Medical assessment of cardiovascular history and monitoring of blood pressure and pulse are important.

Psychiatric effects: New psychotic or manic symptoms may occur. Patients should be assessed for relevant psychiatric history, including bipolar disorder, mania, or hypomania, before treatment.

Urinary effects: Urinary hesitancy or retention may occur.

Priapism: A prolonged or painful erection requires urgent medical attention.

Growth: Growth in pediatric patients should be monitored during treatment.

Contraindications

Strattera is contraindicated in certain situations, including:

• Known hypersensitivity to atomoxetine or its ingredients.
• Concomitant use of a monoamine oxidase inhibitor (MAOI), or use within 14 days of stopping an MAOI.
• Narrow-angle glaucoma.
• Pheochromocytoma or a history of pheochromocytoma.
• Severe cardiovascular or vascular disorders where clinically significant increases in blood pressure or heart rate could cause deterioration.

A licensed healthcare professional should review the full prescribing information before initiating treatment.

Drug Interactions

Atomoxetine may interact with other medicines. Relevant interactions include:

• Monoamine oxidase inhibitors (MAOIs).
• Strong CYP2D6 inhibitors.
• Certain medicines that affect blood pressure.
• Albuterol and other beta-2 agonists, which may require additional cardiovascular monitoring.

Tell your healthcare professional about all prescription medicines, over-the-counter products, and supplements you use.

Storage and Handling

Follow the storage conditions specified on the approved product packaging and the manufacturer’s instructions.

Keep medication out of the reach of children. Do not use a product if its packaging is damaged or if its identity, labeling, or expiry date cannot be verified.

Important Safety Information

Strattera is a prescription medication intended for use under professional medical supervision. It should not be started, stopped, or adjusted without guidance from a qualified healthcare professional.

Patients should discuss their medical history, current medications, allergies, cardiovascular conditions, and relevant psychiatric symptoms with their prescriber.

This product description is for general informational purposes and does not replace the official prescribing information or individualized medical advice.

Frequently Asked Questions (FAQs)

1. What is Strattera used for?

Strattera (atomoxetine) is used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults and children aged 6 years and older.

2. Is Strattera a stimulant medication?

No. Strattera is a non-stimulant ADHD medication that works primarily through norepinephrine reuptake inhibition.

3. What is the active ingredient in Strattera?

The active ingredient is atomoxetine, supplied as atomoxetine hydrochloride in the capsule formulation.

4. What strengths are available?

The U.S. prescribing information lists 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg, and 100 mg capsules.

5. Can Strattera be taken without food?

Yes. The prescribing information states that Strattera may be taken with or without food. Capsules should be swallowed whole.

6. Does Strattera require a prescription?

Strattera is a prescription medication. Availability and dispensing requirements depend on the jurisdiction and applicable regulations.

7. What should I do if I experience side effects?

Contact your healthcare professional for advice. Seek urgent medical attention for serious symptoms such as severe allergic reactions, symptoms of liver injury, significant cardiovascular symptoms, or suicidal thoughts.

Disclaimer

This information is intended for educational and product-information purposes only. Strattera (atomoxetine) should be used only under the supervision of a qualified healthcare professional. Always refer to the current approved product label for complete prescribing, safety, and administration information.